October 02, 2014 12:51 AM ET

Biotechnology

Company Overview of Reliance GeneMedix Limited

Company Overview

Reliance Genemedix Limited, a biopharmaceutical company, develops, manufactures, and distributes biotechnology pharmaceuticals. The company’s biosimilars are a generic version of recombinant therapeutic proteins. It is developing EPOSTIM, which is used as a support therapy for the treatment of acute, chronic, and end-stage renal failure; in cancer-induced and chemotherapy related anemia; in patients undergoing major surgeries; and in AIDS patients on zidovudine treatment. The company is headquartered in Tullamore, Ireland. Reliance GeneMedix Limited is a subsidiary of Reliance Life Sciences BV.

IDA Business & Technology Park

Srah

Tullamore,  

Ireland

24 Employees

Phone:

353 5 793 23572

Fax:

353 5 793 23592

Key Executives for Reliance GeneMedix Limited

Chief Executive Officer
Age: 46
Vice President of Operations
Age: 61
Executive Director
Age: 56
General Manager of Ireland Division
Age: 49
Director of Commercial Operations
Age: 48
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Premier Biomaterials Ltd. Europe
Immcell Limited Europe
SurgaColl Technologies Ltd Europe
Altratech Limited Europe
Ancestry International DNA Company Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Reliance GeneMedix Limited, please visit www.genemedix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.